Pharmaron Beijing Co., Limited announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022. The UK Chemistry, Manufacturing and Control (CMC) business includes operations in Hoddesdon and Cramlington, UK. Tony has been Senior Vice President, Process R&D, since 2019, having been promoted from Vice President, Process Chemistry, a post he held since Pharmaron acquired the MSD Hoddesdon site in 2016.

Prior to this, he was Director of Process Chemistry at MSD where he had worked for 25 years. The UK CMC business currently includes operations in Hoddesdon and Cramlington, UK. The Hoddesdon site offers services in discovery, process development, early-stage cGMP API manufacturing, formulation development and drug product GMP manufacturing.

The Cramlington site, acquired by Pharmaron on January 10, 2022, from Recipharm, offers cGMP manufacturing services ranging from pilot scale to commercial metric ton scale. The expansion of Pharmaron's world-class chemistry and manufacturing portfolio is an important component of its fully integrated platform. Given Tony's leadership success at the Hoddesdon site, he has been appointed to oversee the UK CMC business, which includes the integration of the Cramlington site.

Tony reports directly to Pharmaron Chairman and CEO, Dr. Boliang Lou.